Cannabis Ruderalis

thcscience_admin
Browse history interactively
← Previous editNext edit →
Content deleted Content added
VisualWikitext
Dr. James Schultz (talk | contribs)
196 edits
Added new section
Dr. James Schultz (talk | contribs)
196 edits
Line 14: Line 14:
* A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin<ref>{{cite web|title=A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin|url=https://clinicaltrials.gov/ct2/show/NCT02120833?term=barrier+cream&recr=Completed&rslt=With&rank=3|website=ClinicalTrials.gov|publisher=Johnson & Johnson Consumer and Personal Products Worldwide|accessdate=30 September 2015}}</ref>
* A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin<ref>{{cite web|title=A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin|url=https://clinicaltrials.gov/ct2/show/NCT02120833?term=barrier+cream&recr=Completed&rslt=With&rank=3|website=ClinicalTrials.gov|publisher=Johnson & Johnson Consumer and Personal Products Worldwide|accessdate=30 September 2015}}</ref>
* Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna<ref>{{cite web|last1=Glen|first1=Bowman|title=Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna|url=https://clinicaltrials.gov/ct2/show/NCT00707174?term=barrier+cream&recr=Completed&rslt=With&rank=5|website=ClinicalTrials.gov|publisher=University of Utah|accessdate=30 September 2015}}</ref>
* Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna<ref>{{cite web|last1=Glen|first1=Bowman|title=Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna|url=https://clinicaltrials.gov/ct2/show/NCT00707174?term=barrier+cream&recr=Completed&rslt=With&rank=5|website=ClinicalTrials.gov|publisher=University of Utah|accessdate=30 September 2015}}</ref>
* Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis<ref>Berndt, U., Wigger‐Alberti, W., Gabard, B., & Elsner, P. (2000). Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis, 42(2), 77-80.</ref>


==See also==
==See also==

Revision as of 15:43, 30 September 2015

Shielding Lotions are complex mixtures of chemical agents that bond with dead skin cells on the outer layer of the skin (epidermis) to form a protective external layer. Unlike standard moisturizers which work by hydrating the skin with artificial or natural oils, humectants, emollients, lubricants, etc., shielding lotions actually bond with the skin's outer layer to assist in natural oil and water retention. Shielding lotions also tend to protect against skin irritants.[1][2]

By Indication

Shielding lotions are used to prevent and treat dry skin, improve skin tone and texture, restore moisture balance in the skin, and also treat various dermatological conditions.

In normal skin, shielding lotions prevent moisture and natural oil loss, contributing to healthier and more durable skin.[3] When properly applied, shielding lotions also protect the skin from natural irritants, solvents, poisonous plants and shrubs, as well as the negative effects of skin allergies.[4][5]

Shielding lotions have successfully been used to treat dry skin by helping to retain the skin's natural moisture and oils. They have also been used in the treatment of Eczema,[6][7] Psoriasis,[8] Contact Dermatitis[9] as a sunscreen,[10] and also as protection against skin allergies and irritants.[11]

Clinical Studies

  • Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis[12]
  • A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin[13]
  • Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna[14]
  • Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis[15]

See also

References

  1. ^ D, Williams. "Shielding Lotions - July/August 2005 - Volume 24 - Issue 4 - p 181–182". Dimensions of Critical Care Nursing. Dimensions of Critical Care Nursing. Retrieved 29 September 2015.
  2. ^ H Zhai; H I Maibach. "Barrier creams – skin protectants: can you protect skin?". Wiley Online Library. Journal of Cosmetic Dermatology. Retrieved 29 September 2015.
  3. ^ "New Shielding Lotion Solves the Four Most Common Causes of Dry Skin". The National Skin Care Institute. The National Skin Care Institute. Retrieved 29 September 2015.
  4. ^ Elaine, Larson. "Skin Hygiene and Infection Prevention: More of the Same or Different Approaches?". Clinical Infectuous Diseases. Columbia University School of Nursing. Retrieved 29 September 2015.
  5. ^ H Zhai; H I Maibach. "Barrier creams – skin protectants: can you protect skin?". Wiley Online Library. Journal of Cosmetic Dermatology. Retrieved 29 September 2015.
  6. ^ "A Multi-Center Clinical Trial to Evaluate the Efficacy of an Over-the-Counter Cream in the Management of Mild to Moderate Atopic Dermatitis in Infants and Toddlers". ClinicalTrials.gov. Johnson & Johnson Consumer and Personal Products Worldwide. Retrieved 29 September 2015.
  7. ^ Church, Ronald. "TREATMENT OF INFANTILE ECZEMA." The Lancet 264.6846 (1954): 1020-1021.
  8. ^ Shah, N. V., R. A. Maheshwari, G. U. Sailor, C. J. Aundhia, S. P. Chauhan, and A. R. Javia. "A REVIEW ON ETIOLOGY, TYPES AND TREATMENT OF PSORIASIS."
  9. ^ Swerdlin, Amy, David Rainey, and Frances J. Storrs. "Fragrance mix reactions and lime allergic contact dermatitis." Dermatitis 21.4 (2010): 214-216.
  10. ^ González, Salvador, Manuel Fernández-Lorente, and Yolanda Gilaberte-Calzada. "The latest on skin photoprotection." Clinics in dermatology 26, no. 6 (2008): 614-626.
  11. ^ Du Plessis, S. (2013). The Influence of Different Types of Barrier Creams on Skin Barrier Function (Doctoral dissertation, North-West University, Potchefstroom Campus).
  12. ^ Glen, Bowman. "Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis". ClinicalTrials.gov. University of Utah. Retrieved 30 September 2015.
  13. ^ "A Test to Determine the Usefulness and Safety of a Cream Used on Babies With Dry Itchy Skin". ClinicalTrials.gov. Johnson & Johnson Consumer and Personal Products Worldwide. Retrieved 30 September 2015.
  14. ^ Glen, Bowman. "Combination Therapy With Imiquimod Cream 5% and Tazarotene Cream 0.1% for the Treatment of Lentigo Maligna". ClinicalTrials.gov. University of Utah. Retrieved 30 September 2015.
  15. ^ Berndt, U., Wigger‐Alberti, W., Gabard, B., & Elsner, P. (2000). Efficacy of a barrier cream and its vehicle as protective measures against occupational irritant contact dermatitis. Contact Dermatitis, 42(2), 77-80.
source: https://en.wikipedia.org/w/index.php?title=Shielding_lotion&type=revision&diff=683482270&oldid=683481662

Leave a Reply